Sable Therapeutics

Novel Drug Delivery Platform for Targeted Fat Reduction

  • Stage Concept Only
  • Industry Biotechnology
  • Location New York, NY, USA
  • Currency USD
  • Founded October 2020
  • Employees 10
  • Incorporation Type C-corp
  • Website sabletherapeutics.com

Company Summary

Sable Therapeutics is a biotherapeutics company leveraging novel scientific insights to aid in fat treatment. Our nanomedicine based delivery platform, which can be used with other fat treatments, is engineered to target fat and deliver drug payload. Sable is led by a world-class and experienced management team, including a leading fat metabolism researcher at Columbia University Medical Center, that is passionate about executing this vision.

Team

  • Vedik Navale
    Chief of Staff

    - Associate at Turret Capital
    - Previously Analyst at GIC, biotech & pharma for US public equities
    - Roy and Diana Vagelos Program of Life Sciences and Management at the University of Pennsylvania, The Wharton School

  • Daniel Chai
    Co-Founder, Chief Executive Officer

    -25 years investment across healthcare
    -Founder and managing partner of Turret Capital
    -Serial entrepreneur and global team builder
    -MD Columbia University College of Physicians and Surgeons

  • Li Qiang, Ph.D.
    Co-Founder, Scientific Advisory Board

    -Tenured Associate Professor Pathology & Cell Biology, Columbia University
    -World leading expert in fat metabolism research
    -PhD Biochemistry, Boston University School of Medicine
    -BS Biotechnology, Peking University

  • Ruben Rathnasingham
    Chief Operating Officer

    -20 years in the biomedical industry
    -3x cofounder, 2 acquisitions, 1 IPO
    -Asst. Dean for Health Product Innovation, Dell Medical School, UT Austin
    -Ph.D. MIT

  • Henry Park
    Chief Financial Officer

    -15 years of investment experience
    -Investment Partner at Turret Capital
    -Former Vice President of Magna Investments
    -BS University of Michigan

  • Frank Borchetta
    General Counsel

    -15 years healthcare Intellectual Property
    -GC and Head of IP at Turret Capital
    -Former Loeb & Loeb LLP
    -JD Boston University School of Law

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free